This article focuses on the rationale and evidence supporting the use of concurrent chemotherapy and radiation therapy in the management of locally advanced head and neck cancers. C + RT ...

Optimal treatment for patients with locally advanced head and neck squamous cell carcinoma (HNSCC) unfit for cisplatin ...

For patients with locoregionally advanced head and neck squamous cell carcinoma (HNSCC) with a contraindication for cis ...

New adaptive radiotherapy technique for head and neck cancer can deliver a more robust treatment plan in a shorter timeframe on the MR Linac, compared with the current method used by most radiotherapy ...

Head and neck cancers are the seventh most common ... are disproportionately affected. The chemotherapy drug cisplatin, when ...

Stereotactic body radiotherapy (SBRT ... and correct for tumor and patient movement throughout the treatment. Because of its extreme precision, the CyberKnife system does not require invasive head or ...

Surgical, radiation and medical oncologists in the Baylor St. Luke's Medical Center Dan L Duncan Comprehensive Cancer Center specialize in the diagnosis and treatment of head and neck squamous cell ...

Loss of normal p53 function has been associated with resistance to both chemotherapy ... of an otherwise radiation-resistant squamous cell carcinoma of the head and neck (SCCHN) to radiation.

Combining TRT with EGFR-TKIs significantly improves PFS and OS in EGFR-mutated oligo-organ metastatic NSCLC patients compared to EGFR-TKIs alone. The study suggests personalized treatment approaches, ...

Patients with LAPC or BRPC often receive initial treatment with cytotoxic chemotherapy followed by RT +/- concurrent or maintenance chemotherapy ... randomized Phase 3 study in locally advanced head ...

Expert Rev Anticancer Ther. 2009;9(3):293-302. © 2009 Expert Reviews Ltd. Cite this: Concurrent Chemotherapy and Radiotherapy for Head and Neck Cancer - Medscape ...